TP63 and pancreatic ductal adenocarcinoma: Pancreatic ductal adenocarcinoma and colon cancer patients with high levels of TP63 and Ago2 had a significantly lower overall survival time (Fig. 3E, F, Supplementary Fig. 3A–D).